Article thumbnail

Effectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective study

By Billy E Ngasala, Maja Malmberg, Anja M Carlsson, Pedro E Ferreira, Max G Petzold, Daniel Blessborn, Yngve Bergqvist, José P Gil, Zul Premji and Andreas Mårtensson
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3065443
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2011). A: Efficacy and effectiveness of artemether-lumefantrine after initial and repeated treatment in children < 5 years of age with acute uncomplicated Plasmodium falciparum malaria in rural Tanzania: a randomized trial. Clin Infect Dis
  2. (2007). A: Influence of consecutive-day blood sampling on polymerase chain reaction-adjusted parasitological cure rates in an antimalarial-drug trial conducted in Tanzania. J Infect Dis
  3. (2007). Artemether-lumefantrine versus dihydroartemisininpiperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials
  4. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria [http:// www.who.int/malaria/publications/atoz/whohtmrbm200350/en/].
  5. (2011). Björkman A: malaria rapid testing by community health workers is effective and safe for targeting malaria treatment: randomised crossover trial in Tanzania. PLoS One
  6. (2002). Case management of malaria in under-fives at primary health care facilities in a Tanzanian district. Trop Med Int Health
  7. (1999). Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine. Clin Pharmacokinet
  8. (2007). Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper.
  9. (2004). dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev
  10. (2003). Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Trop Med Int Health
  11. (1997). Esposito F: A community-based programme to provide prompt and adequate treatment of presumptive malaria in children. Trans R Soc Trop Med Hyg
  12. (2006). Feasibility and acceptability of the use of artemether-lumefantrine in the home management of uncomplicated malaria in children 6-59 months old in Ghana. Trop Med Int Health
  13. (2002). Genotyping of Plasmodium spp. Nested PCR. Methods Mol Med
  14. Global AMDP database - WHO African region.
  15. Guidelines for the treatment of malaria,
  16. (2006). Guthmann JP: Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosagerelated findings from a clinical trial in Uganda. Malar J
  17. (2005). Guthmann JP: Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet
  18. Health Organization/Special Programme for Research and Training
  19. (2008). How antimalarial drug resistance affects post-treatment prophylaxis.
  20. Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia. Malar J 2009, 8(Suppl 1):S8.
  21. JP: In vivo selection of Plasmodium falciparum parasites carrying the chloroquine-susceptible pfcrt K76 allele after treatment with artemether-lumefantrine in Africa. JI n f e c tD i s2009,
  22. (2005). JP: In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis
  23. (2006). JP: Multiplex PCR-RFLP methods for pfcrt, pfmdr1 and pfdhfr mutations in Plasmodium falciparum. Mol Cell Probes
  24. (2009). Lalloo DG: Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxinepyrimethamine in the treatment of uncomplicated malaria in Malawi. Malar J
  25. (2008). Malaria Partnership: The Global Malaria Action Plan
  26. (2002). ML: Performance appraisal of rapid on-site malaria diagnosis (ICT malaria Pf/Pv test) in relation to human resources at village level in Myanmar. Acta Trop
  27. (2006). National guidelines for malaria diagnosis and treatment. Dar es Salaam;
  28. (2002). NJ: The evolution of drug-resistant malaria: the role of drug elimination half-life.
  29. (2009). Nzila A: In vitro activities of piperaquine, lumefantrine, and dihydroartemisinin in Kenyan Plasmodium falciparum isolates and polymorphisms in pfcrt and pfmdr1. Antimicrob Agents Chemother
  30. (2009). Oduola AM: Selection of Plasmodium falciparum multidrug resistance gene 1 alleles in asexual stages and gametocytes Ngasala et al.
  31. (2008). Organization: WHO/HTM/GMP/2008.1. World Malaria Report
  32. Organization: WHO/HTM/MAL/2005.1101. The roll back malaria strategy for improving access to treatment through home management of malaria [http://www.who.int/malaria/publications/atoz/
  33. (2007). Ouedraogo JB: Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis
  34. (2008). Pagnoni F: Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J
  35. (1998). Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients.
  36. (2000). RH: Teaching mothers to provide home treatment of malaria in Tigray, Ethiopia: a randomised trial. Lancet
  37. (2007). RL: Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob Agents Chemother
  38. (2010). SE: The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria. Trop Med Int Health
  39. (2006). Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother
  40. (1994). Shiff CJ: Laboratory diagnosis of malaria by village health workers using the rapid manual ParaSight-F test. Trans R Soc Trop Med Hyg
  41. (2006). Staedke SG: Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials
  42. (2007). Staedke SG: Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence.
  43. (2008). Talisuna AO: Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.
  44. (2008). The Millennium Development Goals Report
  45. (2005). Whitty CJ: Amodiaquine alone, amodiaquine +sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemetherlumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet
  46. (2008). WHO: World Malaria Report
  47. (2000). WM: Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/ Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum. J Infect Dis